imazodan has been researched along with pelrinone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagli, J; Bogri, T; Lee, DK; McQuillan, J; Palameta, B; Peseckis, S; Rakhit, S | 1 |
| Erhardt, PW | 1 |
| Cantor, E; Chou, YL; Erhardt, PW; Hagedorn, AA; Ingebretsen, WR; Lampe, JW; Lumma, WC; Pang, D; Pease, CA; Wohl, RA | 1 |
1 review(s) available for imazodan and pelrinone
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
2 other study(ies) available for imazodan and pelrinone
| Article | Year |
|---|---|
Chemistry and positive inotropic effect of pelrinone and related derivatives. A novel class of 2-methylpyrimidones as inotropic agents.
Topics: Animals; Blood Pressure; Cats; Dogs; Heart Rate; Models, Molecular; Myocardial Contraction; Pyrimidines; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Structure-Activity Relationship | 1988 |
Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Ferrets; Heart Rate; Imidazoles; Myocardial Contraction; Papillary Muscles; Stimulation, Chemical; Structure-Activity Relationship | 1987 |